Genkwanin mitigates renal fibrosis by reprogramming profibrotic signaling and restoring TFEB-mediated autophagy
Frontiers in Pharmacology · 13.08.2026 · 17
DOI: 10.3389/fphar.2026.1861855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 13.08.2026. Verfasst von Shen Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Renal fibrosis is a common pathological outcome of chronic kidney disease and is characterized by persistent profibrotic signaling and impaired cellular homeostasis. Genkwanin (GAK), a natural flavonoid compound, has shown anti-inflammatory and antioxidant activities in several disease models. However, its role in renal fibrosis remains unclear. Materials and methods We investigated the antifibrotic effects of GAK in a TGF-β1–induced HK-2 cell model and a unilateral ureteral obstruction (UUO) mouse model. EMT- and fibrosis-related changes were assessed by RT-qPCR, Western blotting, immunofluorescence, and histological staining. The involvement of TGF-β1/SMAD2 and β-catenin signaling was examined using pharmacological modulators. Autophagic flux was evaluated by tandem mCherry-GFP-LC3 analysis, transmission electron microscopy, and autophagy-related protein expression. TFEB inhibition was used to further assess the role of lysosome–autophagy regulation.
Results
GAK significantly attenuated TGF-β1–induced EMT and extracellular matrix accumulation in HK-2 cells and reduced renal fibrotic injury in UUO mice. Mechanistically, GAK decreased p-SMAD2 expression and limited β-catenin nuclear redistribution, indicating suppression of both TGF-β1/SMAD2 and β-catenin signaling. In addition, GAK improved autophagic flux and increased TFEB expression. Inhibition of TFEB partially weakened the protective effects of GAK on fibrosis-related and autophagy-related changes, suggesting that TFEB-mediated lysosome–autophagy function contributes to its antifibrotic action.
Conclusion
In conclusion, GAK alleviates renal fibrosis in vitro and in vivo , at least in part, by suppressing TGF-β1/SMAD2 and β-catenin signaling and by restoring TFEB-associated autophagic flux.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Provincial Clinical Medical Research Center for Minimally Invasive Treatment of Urology, Wuhan, China.
- Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Nephrology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
- First Department of Urology, First Affiliated Hospital of Kunming Medical University, Kunming, China.
Zitieren
APA
Wang, S., He, Y., Gan, X., Kang, H., Zhou, Z., & He, Z. (2026). Genkwanin mitigates renal fibrosis by reprogramming profibrotic signaling and restoring TFEB-mediated autophagy. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1861855
Vancouver
Wang S, He Y, Gan X, Kang H, Zhou Z, He Z. Genkwanin mitigates renal fibrosis by reprogramming profibrotic signaling and restoring TFEB-mediated autophagy. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1861855
BibTeX
@article{Wang2026,
author = {Wang, Shen and He, Yu and Gan, Xin and Kang, Hao and Zhou, Zhu and He, ZongHai},
title = {Genkwanin mitigates renal fibrosis by reprogramming profibrotic signaling and restoring TFEB-mediated autophagy},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1861855}
}
EUVIMED